This site is intended for US audiences only.

Skip to content

Main Navigation

For Patients
For Healthcare Professionals
Resources

University of Illinois Cancer Center

Posted on April 3, 2024 (July 19, 2024) by lum-dev

Chicago, IL 60612

Post navigation

AdventHealth Cancer InstituteMUSC Hollings Cancer Center

Ficlatuzumab is an investigational drug and has not yet been approved by the US Food and Drug Administration (FDA).

Footer Navigation

Terms of Use
Privacy Policy
Cookie Policy
Contact Us

© 2024 AVEO Pharmaceuticals, Inc. All rights reserved. US-MAT-00305 4/24